View Older Stories View More Recent Stories
-
Wedbush Morgan Upgrades Edwards Lifesciences (EW) to Neutral
-
Wedbush Morgan Upgrades Abiomed (ABMD) to Neutral; Potential Near-Term Catalysts
-
Wedbush Morgan Upgrades Polaris Industries (PII) to Outperform; Continuing Market Share Gains
-
Wedbush Morgan Maintains a 'Neutral' on ShoreTel (SHOR); Optimistic on Company’s Growth Prospects
-
Wedbush Morgan Upgrades GSI Commerce (GSIC) to Outperform
-
Wedbush Morgan Downgrades The Medicines Company (MDCO) to Underperform
-
Wedbush Morgan Believes Levadex and Tempo Now Make MAP Pharmaceuticals (MAPP) an Acquisition Target
-
Wedbush Ups Target on Advent (ADVS) to $44, Reiterates Buy
-
Wedbush Morgan Upgrades 3PAR, Inc. (PAR) to Outperform; Gaining Traction
-
Wedbush Morgan Upgrades Concur Technologies (CNQR) to Neutral; Customer Growth Remains Strong
-
Wedbush Morgan Upgrades Salesforce.com (CRM) to Neutral; Channel Checks More Positive
-
Wedbush Starts Teradata (TDC) at Underperform, $22.50 Price Target
-
Wedbush Morgan Adds McDonald's (MCD) To Best Ideas List, Sees Dividend Increase
-
Wedbush Starts ESCO Tech. (ESE) at Buy, $42 Target
-
Wedbush Morgan Starts Exide Technologies (XIDE) at Outperform
-
Wedbush Morgan Starts Polypore International Inc. (PPO) at Neutral
-
Wedbush Morgan Starts Maxwell Technologies (MXWL) at Outperform
-
Wedbush Morgan Starts Echelon (ELON) at Outperform
-
Wedbush Morgan Starts Acuity Brands (AYI) at Neutral
-
Wedbush Removes STEC (STEC) from Best Ideas List, Raises Price Target to $45
-
Wedbush Morgan Upgrades Aruba Networks (ARUN) to Outperform; Adjusts Estimates & Price Target
-
Wedbush Morgan Maintains an 'Outperform' on Osiris Therapeutics (OSIR); Slashes Price Target
-
Wedbush Morgan Upgrades ShoreTel (SHOR) to Neutral
-
Wedbush Morgan Upgrades Intersil Corporation (ISIL) to Outperform
-
Wedbush Morgan Downgrades Netgear (NTGR) to Neutral; Shares Fully Valued
-
Wedbush Morgan Maintains an 'Outperform' on Starent Networks (STAR); Adds to 'Best Ideas' List
-
Wedbush Starts Finish Line (FINL) at Outperform, $11 Price Target
-
Wedbush Morgan Upgrades Ixia (XXIA) to Neutral; Shares Reach Price Target, Demand Environment Better
-
Wedbush Morgan Upgrades Starent Networks (STAR) to Outperform; Attractive Entry Point
-
Wedbush Morgan Reiterates an 'Outperform' on CyberSource (CYBS); Undue Pressure Presents Opportunity
-
Wedbush Morgan Upgrades Marvel Entertainment (MVL) to Neutral
-
Wedbush Boosts Target on Intel (INTC) to $24; Reiterates Outperform
-
Wedbush Morgan Reiterates an 'Outperform' on J.Crew Group (JCG); Raises Estimates & Price Target
-
Wedbush Morgan Maintains a 'Neutral' on VeriFone (PAY); Raises Estimates & Price Target
-
Notable Analyst Rating Changes 8/27: GHL, DLTR, WHR, KNX, WAG, FWLT Upgraded; ATRO, JTX, SIGM, TREE Downgraded
-
Wedbush Morgan Maintains an 'Outperform' on Williams-Sonoma (WSM); Raises PT & Estimates
-
Wedbush Morgan Maintains an Outperform Rating on Guess? (GES); Raises Price Target & Estimates
-
Wedbush Morgan Upgrades Dollar Tree Stores (DLTR) to Neutral; Strong Top-Line Execution
-
Notable Analyst Rating Changes 8/26: STJ, GMR, KMT, CP Upgraded; BKC, AMED, MDAS Downgraded
-
Wedbush Morgan Upgrades Willdan Group (WLDN) to Neutral
-
Wedbush Morgan Downgrades Burger King (BKC) to Neutral; Prefers McDonald's (MCD)
-
Wedbush Morgan Upgrades Radiant Systems (RADS) to Outperform; Sees Upside to Current Expectations
-
Notable Analyst Rating Changes 8/24: AXP, DELL, AMD, BBD, EAT Upgraded; NOK, TOL, SWHC, PNC, SYK Downgraded
-
Morning Movers 8/24: CHIC, WCRX, FNM, NPD, FRE Higher; SWHC, VRX, NRP Lower
-
Wedbush Morgan Downgrades Smith & Wesson (SWHC) to Neutral: Sees Slowdown In Demand
-
Wedbush Morgan Maintains an 'Outperform' on Gymboree (GYMB); Raises Price Target & Estimates
-
Wedbush Morgan Initiates Coverage on Kopin Corporation (KOPN) with an Outperform; Improving Fundamentals
-
Notable Analyst Rating Changes 8/18: GS, AXP, POR, GLW, BSX Upgraded;
-
Wedbush Morgan Initiates Coverage on Texas Instruments (TXN) with an Outperform; Accelerating Analog Momentum
-
Wedbush Morgan Assumes Coverage on First Solar (FSLR) with an Outperform; Adjusts 2009-10 Estimates
